BCL-2 Family Proteins: Changing Partners in the Dance Towards Death

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2017 Nov 18

PMID 29149100

Citations 639

Authors

Justin Kale

Elizabeth J Osterlund

David W Andrews

Affiliations

Soon will be listed here.

Abstract

The BCL-2 family of proteins controls cell death primarily by direct binding interactions that regulate mitochondrial outer membrane permeabilization (MOMP) leading to the irreversible release of intermembrane space proteins, subsequent caspase activation and apoptosis. The affinities and relative abundance of the BCL-2 family proteins dictate the predominate interactions between anti-apoptotic and pro-apoptotic BCL-2 family proteins that regulate MOMP. We highlight the core mechanisms of BCL-2 family regulation of MOMP with an emphasis on how the interactions between the BCL-2 family proteins govern cell fate. We address the critical importance of both the concentration and affinities of BCL-2 family proteins and show how differences in either can greatly change the outcome. Further, we explain the importance of using full-length BCL-2 family proteins (versus truncated versions or peptides) to parse out the core mechanisms of MOMP regulation by the BCL-2 family. Finally, we discuss how post-translational modifications and differing intracellular localizations alter the mechanisms of apoptosis regulation by BCL-2 family proteins. Successful therapeutic intervention of MOMP regulation in human disease requires an understanding of the factors that mediate the major binding interactions between BCL-2 family proteins in cells.

Citing Articles

Unraveling the Osteogenic Activity and Molecular Mechanism of an Antioxidant Collagen Peptide in MC3T3-E1 Cells.

Wang Y, Wang Y, Zhuang X, Zhang Y, Fang B, Fu Y Nutrients. 2025; 17(5).

PMID: 40077694 PMC: 11902006. DOI: 10.3390/nu17050824.

Autophagy and Programmed Cell Death Modalities Interplay in HIV Pathogenesis.

Lamsira H, Sabatini A, Ciolfi S, Ciccosanti F, Sacchi A, Piacentini M Cells. 2025; 14(5).

PMID: 40072080 PMC: 11899401. DOI: 10.3390/cells14050351.

Oncogenic and microenvironmental signals drive cell type specific apoptosis resistance in juvenile myelomonocytic leukemia.

Koleci N, Wu Y, Wehner N, Rajak J, Mittapalli V, Mergner J Cell Death Dis. 2025; 16(1):165.

PMID: 40057493 PMC: 11890777. DOI: 10.1038/s41419-025-07479-2.

Synergistic effects of 6-shogaol and hyperthermia on ACHN renal cancer cells: modulation of ROS and heat shock pro-teins in cancer therapy.

Ahn C, Baek S Front Pharmacol. 2025; 16:1522285.

PMID: 40051570 PMC: 11882530. DOI: 10.3389/fphar.2025.1522285.

Imbalance in redox homeostasis is associated with neurodegeneration in the murine model of Tay-Sachs disease.

Basirli H, Ates N, Seyrantepe V Mol Biol Rep. 2025; 52(1):282.

PMID: 40042748 DOI: 10.1007/s11033-025-10380-y.

References

Nechushtan A, Smith C, Hsu Y, Youle R . Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 1999; 18(9):2330-41. PMC: 1171316. DOI: 10.1093/emboj/18.9.2330. View

Zhang H, Guttikonda S, Roberts L, Uziel T, Semizarov D, Elmore S . Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene. 2010; 30(16):1963-8. DOI: 10.1038/onc.2010.559. View

Kuwana T, Mackey M, Perkins G, Ellisman M, Latterich M, Schneiter R . Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 2002; 111(3):331-42. DOI: 10.1016/s0092-8674(02)01036-x. View

Sarosiek K, Chi X, Bachman J, Sims J, Montero J, Patel L . BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response. Mol Cell. 2013; 51(6):751-65. PMC: 4164233. DOI: 10.1016/j.molcel.2013.08.048. View

Gahl R, Dwivedi P, Tjandra N . Bcl-2 proteins bid and bax form a network to permeabilize the mitochondria at the onset of apoptosis. Cell Death Dis. 2016; 7(10):e2424. PMC: 5133987. DOI: 10.1038/cddis.2016.320. View

Souers A, Leverson J, Boghaert E, Ackler S, Catron N, Chen J . ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013; 19(2):202-8. DOI: 10.1038/nm.3048. View

Deng X, Gao F, Flagg T, May Jr W . Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci U S A. 2003; 101(1):153-8. PMC: 314154. DOI: 10.1073/pnas.2533920100. View

Leber B, Lin J, Andrews D . Still embedded together binding to membranes regulates Bcl-2 protein interactions. Oncogene. 2010; 29(38):5221-30. PMC: 6459407. DOI: 10.1038/onc.2010.283. View

Pecot J, Maillet L, Le Pen J, Vuillier C, de Carne Trecesson S, Fetiveau A . Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance. Cell Rep. 2016; 17(12):3347-3358. DOI: 10.1016/j.celrep.2016.11.064. View

10.

Iyer S, Anwari K, Alsop A, Yuen W, Huang D, Carroll J . Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies. Nat Commun. 2016; 7:11734. PMC: 4890306. DOI: 10.1038/ncomms11734. View

11.

Aranovich A, Liu Q, Collins T, Geng F, Dixit S, Leber B . Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Mol Cell. 2012; 45(6):754-63. DOI: 10.1016/j.molcel.2012.01.030. View

12.

Billen L, Kokoski C, Lovell J, Leber B, Andrews D . Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol. 2008; 6(6):e147. PMC: 2422857. DOI: 10.1371/journal.pbio.0060147. View

13.

Brouwer J, Westphal D, Dewson G, Robin A, Uren R, Bartolo R . Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers. Mol Cell. 2014; 55(6):938-946. DOI: 10.1016/j.molcel.2014.07.016. View

14.

Scorrano L, Oakes S, Opferman J, Cheng E, Sorcinelli M, Pozzan T . BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science. 2003; 300(5616):135-9. DOI: 10.1126/science.1081208. View

15.

Gardai S, Hildeman D, Frankel S, Whitlock B, Frasch S, Borregaard N . Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 2004; 279(20):21085-95. DOI: 10.1074/jbc.M400063200. View

16.

Kutuk O, Letai A . Regulation of Bcl-2 family proteins by posttranslational modifications. Curr Mol Med. 2008; 8(2):102-18. DOI: 10.2174/156652408783769599. View

17.

Chi X, Kale J, Leber B, Andrews D . Regulating cell death at, on, and in membranes. Biochim Biophys Acta. 2014; 1843(9):2100-13. DOI: 10.1016/j.bbamcr.2014.06.002. View

18.

Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X . Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol. 2000; 2(10):754-61. DOI: 10.1038/35036395. View

19.

Eskes R, Antonsson B, Osen-Sand A, Montessuit S, Richter C, Sadoul R . Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J Cell Biol. 1998; 143(1):217-24. PMC: 2132823. DOI: 10.1083/jcb.143.1.217. View

20.

Rehm M, Dussmann H, Janicke R, Tavare J, Kogel D, Prehn J . Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J Biol Chem. 2002; 277(27):24506-14. DOI: 10.1074/jbc.M110789200. View